Episode 134 | The Neuropsychology of Stroke – With Dr. Ronald Lazar
In this episode, we discuss the neuropsychology of stroke with Dr. Ronald Lazar. Specific topics covered include definitions of cerebrovascular terminology, stroke epidemiology, neurovascular anatomy, neuroimaging techniques, risk factors, health disparities, prognosis, mental health factors, and both acute and long-term treatment strategies.
Episode 52 | The Hierarchical Taxonomy of Psychopathology (HiTOP) – With Dr. Robert Latzman
Our current nosology of psychopathology relies on a categorical model that has notable limitations. For example, this medical model of classifying mental disorders does not account for the significant heterogeneity of symptom presentations across psychopathology. Today, we speak with Robert Latzman, Ph.D., to discuss the Hierarchical Taxonomy of Psychopathology (HiTOP), an alternative nosology that uses factor analysis to address the issues with our current diagnostic classification standard.
Episode 76 | Aerospace Neuropsychology – With Dr. Randy Georgemiller
A high level of cognitive functioning is crucial to the safe and competent operation of aircraft. Neuropsychologists are increasingly called upon to perform cognitive evaluations of commercial airline pilots and these evaluations are unique in many ways compared to more conventional clinical assessments in hospital settings. In this episode, we discuss the ins and outs of aerospace neuropsychology, including important clinically relevant evidence-based advice and guidance for neuropsychologists looking to extend their practice by evaluating aviators.
Episode 50 | Non-CNS Cancer and Cognition – With Dr. Mike Parsons
The cognitive consequences of non-central nervous system (non-CNS) cancer and cancer-related treatments did not become the subject of scientific investigation until recently and is still a growing area of research. Contemporary studies have made it clear that neuropsychology is an integral part of the evaluation and care of individuals with cancer. Today we talk with Michael Parsons, Ph.D., ABPP-CN, about the evaluation of cognitive change due to cancer and cancer-related treatment, factors that influence cognitive decline in these patients, and how interdisciplinary work can benefit these patients.